Advertisement

LFMD

LifeMD, Inc.

Healthcare · USD

Set alert

Price alert · LFMD

All alert types
2.29 USD -0.03 -1.29%
As of Oct 30, 2026 Extended hours 2.33 +1.75%
Bid
2.29 × 2
Ask
2.30 × 2
2.24 Day range 2.35
2.08 52-week range 5.91
YTD
-32.84%
1 year
-60.52%
Open
2.30
Prev close
2.32
Mkt cap
110.51M
Vol
599.13K
Avg vol
834.21K
EPS
-0.51
P/E
0.00
Div yield
0.00%
More statistics
Low
2.24
High
2.35
Forward P/E
-124.75
Beta
1.23
Short ratio
7.78
Inst. own
40.48%
Dividend
0.00
Ex-div date
50-d avg
5.34
200-d avg
7.01
1y target
12.00

5D chart

Chart tools
Interval
LFMD five-day price chart2.062.142.232.312.39Oct 23Oct 26Oct 27Oct 28Oct 29

Key statistics

Market cap
216.13M
Enterprise value
207.61M
Trailing P/E
0.00
Forward P/E
-124.75
PEG ratio
0.00
Price / sales
1.12
Price / book
0.00
EPS (TTM)
-0.64
Beta
1.23
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-11.66%
Revenue (TTM)
193.06M
Revenue growth
38.30%
Free cash flow
18.01M
Total cash
37.59M
Total debt
25.14M
Return on equity
0.00%
Shares outstanding
43.31M
Short % of float
16.08%
50-day average
5.34
200-day average
7.01

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 12.00 +424.0% upside
Target (low)
7.00
Target (mean)
12.00
Target (high)
16.00
Ratings (0m) 9 8 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy7
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate 0.14.

Earnings history

Financials — quick view

All financials
LFMD Revenue — quarterly 47.28M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
LFMD Net income — quarterly -7.08M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
LFMD EPS — quarterly -0.16
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

LFMD recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 7, 2024Sep 1, 2024-0.10-0.14-0.04-40.00%
Aug 7, 2024Jun 1, 2024-0.13-0.19-0.06-46.15%
May 8, 2024Mar 1, 2024-0.13-0.19-0.06-46.15%
Mar 11, 2024Dec 1, 2023-0.14-0.12+0.02+14.29%
Nov 8, 2023Sep 1, 2023-0.18-0.20-0.02-11.11%
Aug 9, 2023Jun 1, 2023-0.09-0.23-0.14-155.56%

Upgrades / downgrades

LFMD analyst upgrades and downgrades
DateFirmActionFromTo
Dec 10, 2024Lake Streetinit—Buy
Dec 4, 2024Mizuhoinit—Neutral
Nov 11, 2024HC Wainwright & Co.reitBuyBuy
Sep 20, 2024Cantor FitzgeraldreitOverweightOverweight
Aug 20, 2024Cantor FitzgeraldreitOverweightOverweight
Aug 9, 2024Cantor FitzgeraldreitOverweightOverweight

About LifeMD, Inc.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Sector
Healthcare
Industry
Health Information Services
Country
United States
Website
lifemd.com

News

Your note

Sign in to keep a note on LFMD — it syncs with the Stock Master app.

Insider holders

LFMD insider holders
InsiderRelationLatest transactionDateShares held
ALVAREZ NICHOLAS POfficerStock Award(Grant)Mar 20, 2024405,000
DITROLIO JOSEPHDirectorStock Award(Grant)Dec 5, 2024251,048
GALLUPPI STEFANOfficerPurchaseSep 10, 202445,449
JINDAL PIYUSHDirectorStock Award(Grant)Jul 16, 2024362,335
MACRAE CALUM ARCHIBALDDirectorStock Award(Grant)Apr 25, 202416,500
SCHREIBER JUSTINChief Executive OfficerSaleDec 1, 20240

Institution ownership

LFMD institution ownership
Holder% heldSharesValueReported
Blackrock Inc.5.73%2,481,76112.38MSep 29, 2024
Vanguard Group Inc3.93%1,702,5668.50MSep 29, 2024
Divisadero Street Capital Management, LP3.48%1,508,4037.53MSep 29, 2024
State Street Corporation2.67%1,155,4955.77MSep 29, 2024
Royce & Associates LP2.08%901,0414.50MSep 29, 2024
Geode Capital Management, LLC1.89%819,2334.09MSep 29, 2024

Fund ownership

LFMD fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.15%932,5284.65MSep 29, 2024
iShares Russell 2000 ETF2.04%882,9484.41MOct 30, 2024
Royce Small-Cap Opportunity Fund1.20%517,8782.58MSep 29, 2024
SPDR (R) Ser Tr-SPDR� Kensho New Economies Composite ETF1.14%492,7872.46MSep 29, 2024
Vanguard Extended Market Index Fund1.04%449,9452.25MSep 29, 2024
Fidelity Small Cap Index Fund0.83%357,8711.79MAug 30, 2024
Advertisement